leisure time -WSS

leisure time

author：comprehensive 2025-09-28 20:32:48 - browse：5

A display of TVs against an orange background. -- health policy coverage from STAT — Adobe

WASHINGTON — Government regulators may soon decide whether to crack down on distracting visuals in television drug commercials or require subtitles about side effects, a regulation that’s been 13 years in the making.

White House budget experts are reviewing changes to the regulation of broadcast drug advertisements that the Food and Drug Administration proposed in 2010, according to the Office of Management and Budget website. That proposal aimed to make commercials present drug risks in a manner that consumers notice and understand.

Drug ads have long been controversial. Aside from New Zealand, the United States is the only country that allows drug makers to advertise to consumers. Critics of drug ads say they pose consumer safety concerns by bombarding the public with promotions that distract viewers from potential side effects. Drug companies say commercials spark conversations between patients and doctors that promote clinically beneficial prescribing.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： Cytokinetics CEO Robert Blum is on my Worst CEO shortlist again

WSS

HPV vaccine, cervical cancer study delivers historic results

TikTok, Instagram influencers need more rules for drug ads

Cardiologists urge adding sexual orientation, gender identity to health records

Sanofi to acquire U.S. biotech Inhibrx in $2.2 billion deal

HPV vaccine, cervical cancer study delivers historic results

Addressing health care workers' trauma can help fight burnout

knowledge

leisure time

explore

What does generative AI mean for health care? We asked experts

H5N1 virus can be tracked in retail milk, scientists say

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Mass General, Mayo Clinic look to monetize custom

FDA approval of Sarepta Duchenne genetic therapy gives me hope

UnitedHealth argues against case alleging wrongful AI care denials

Heart attack and stroke risk calculators need revising

Prior authorization reform is both possible and imperative

Jerome Adams on the need for new antivirals for Covid

Liver decline slowed by off

explore

HPV vaccine, cervical cancer study delivers historic results

For longer

UnitedHealth argues against case alleging wrongful AI care denials

Mass General, Mayo Clinic look to monetize custom

As a primary care physician, here's how I hope to partner with AI

Making the case for fair compensation in clinical trials

knowledge

leisure time

hotspot

hotspot